Raman Spectroscopy In-Depth Focus
In this Raman Spectroscopy In-Depth Focus: Subvisible particle identification in protein-based formulations by Raman spectroscopy; Raman spectroscopy as a blood glucose monitoring tool...
List view / Grid view
In this Raman Spectroscopy In-Depth Focus: Subvisible particle identification in protein-based formulations by Raman spectroscopy; Raman spectroscopy as a blood glucose monitoring tool...
Subvisible particles in protein-based formulations can have different origins. Particles can be extrinsic (unexpected foreign material), intrinsic (from the production environment or primary packaging), and inherent (from the formulation). It is important that inherent particles (protein agglomerates) are distinguished from the other two types and that the extrinsic and intrinsic…
In this Formulation Development & Delivery In-Depth Focus: A report on the use of freeze-drying to develop orally disintegrating tablets; a review of mucosal drug delivery; an interview on drug delivery through the skin; and a profile of three analytical technologies used to develop drug delivery systems...
In this supplement, we've brought together a collection of interesting posters from leading companies in order to celebrate cutting-edge research in the pharmaceutical industry and to share with our readers some of the varied work being carried out by their colleagues...
In Issue #3 2017: In-Depth Focuses covering Raman Spectroscopy, Separations & Purifications, Formulation Development & Delivery; Guide To Testing Services; GMP and mutual recognition; Regulatory Insight; RMMs; Microbiology Series; and much more...
The FDA has approved the cryopreserved formulation of ReNeuron’s human retinal progenitor cell (hRPC) therapeutic candidate...
In this infographic, the Royal Pharmaceutical Society offers a more complete picture from excipient experts...
This whitepaper describes how deploying such a platform can provide end-to-end visibility across Pre-formulations and Formulations Development and expedite the identification and progression of safe, efficacious formulations...
New research projects that aim to improve the complex formulation processes used to manufacture products such as toothpastes, inhalers, films that coat solar cells and pharmaceuticals are to receive significant funding from the Engineering and Physical Sciences Research Council (EPSRC).
A defining characteristic of inhaled drug delivery is variability in the dose received by the patient, as a result of physiology, for example, or the technique applied during use. This variability directly affects clinical outcomes so reducing it to a minimum is an important goal for the industry...
For the pharmaceutical scientist, the journey of an active molecule from the end of its synthetic pathway and crystallisation to its ultimate site of action is a fascinating one, and one that is necessary to understand...
Read the free-to-view digital version of the latest issue of European Pharmaceutical Review...
Understanding the effect of API changes in pharmaceutical processing; Improving the consistency of MDI drug delivery; and Expert Views with DDF Summit and Eurofins Lancaster Laboratories...
The first part of an in-depth article on Quality by Design (QbD), published in European Pharmaceutical Review in December 2016, focused on designing quality in to a pharmaceutical drug product by considering dosage form design, and understanding the importance of active pharmaceutical ingredients’ (APIs’) and excipients’ properties.
21 February 2017 | By Viavi Solutions Inc.
This webinar presented the use of MicroNIR PAT for monitoring the endpoint of powder blending operations and discussed challenges that need to be addressed for successful implementation...